Tilray Medical Launches Redecan Cannabis Brand in Australia

The country now offers products in 20 countries.

Screenshot 2024 09 18 At 2 33 36 Pm
Redecan

Tilray Medical, a division of Tilray Brands, today announced the launch of Redecan EU-GMP certified medical cannabis products in Australia.

The following Redecan products are now available for medical cannabis patients in Australia:

  • Redecan PC THC28 Purple Churro – 15g

  • Redecan SA THC28 Space Age Cake – 15g

Tilray continues to be one of the leading providers of EU-GMP certified medical cannabis to patients, physicians, pharmacies, hospitals, governments, and researchers across the globe, and today offers a comprehensive portfolio of THC and CBD products in over 20 countries. In furtherance of its mission, Tilray has supported medical trials globally studying the efficacy of medical cannabis as a treatment for indications including fibromyalgia, pediatric epilepsy, refractory pediatric epilepsy, cancer-induced nausea and vomiting, HIV, essential tremor, breast cancer disorders, post-traumatic stress disorder, and alcohol use disorders.

More in News